David Waltz

61 total papers · 7.0k total citations
47 papers, 5.2k citations indexed

About

David Waltz is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, David Waltz has authored 47 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 6 papers in Immunology and Allergy. Recurrent topics in David Waltz's work include Cystic Fibrosis Research Advances (34 papers), Neonatal Respiratory Health Research (16 papers) and Tracheal and airway disorders (15 papers). David Waltz is often cited by papers focused on Cystic Fibrosis Research Advances (34 papers), Neonatal Respiratory Health Research (16 papers) and Tracheal and airway disorders (15 papers). David Waltz collaborates with scholars based in United States, Australia and United Kingdom. David Waltz's co-authors include Harold A. Chapman, Ying Wei, Michael W. Konstan, Gautham Marigowda, Bonnie W. Ramsey, Xiaohong Huang, Michael Boyle, Steven M. Rowe, Susanna A. McColley and Philip M. Boiselle and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David Waltz

47 papers receiving 5.0k citations

Hit Papers

Lumacaftor–Ivacaftor in P... 1994 2026 2004 2015 2015 1994 2014 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
    2015 1.2k citations Claire Wainwright, J.S. Elborn et al. New England Journal of Medicine profile →
  2. Identification of the urokinase receptor as an adhesion receptor for vitronectin.
    1994 517 citations Ying Wei, David Waltz et al. Journal of Biological Chemistry profile →
  3. A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
    2014 335 citations Michael Boyle, Scott C. Bell et al. The Lancet Respiratory Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Waltz 3.4k 985 960 566 536 47 5.2k
Carol A. Wilke 2.4k 0.7× 439 0.4× 1.3k 1.3× 469 0.8× 469 0.9× 75 6.1k
David K. Madtes 1.9k 0.5× 372 0.4× 1.1k 1.1× 278 0.5× 878 1.6× 73 4.9k
Richard J. Riese 1.0k 0.3× 1.1k 1.1× 1.6k 1.6× 395 0.7× 1.0k 1.9× 76 7.1k
Mark R. Looney 1.9k 0.5× 305 0.3× 1.5k 1.5× 274 0.5× 903 1.7× 97 6.8k
Darrell Pilling 1.1k 0.3× 294 0.3× 1.7k 1.7× 526 0.9× 449 0.8× 90 6.7k
Philippe Lesavre 1.9k 0.5× 253 0.3× 1.3k 1.4× 680 1.2× 1.1k 2.0× 107 6.5k
C A Hébert 908 0.3× 417 0.4× 1.3k 1.3× 855 1.5× 376 0.7× 34 5.6k
Jack B. Cowland 818 0.2× 677 0.7× 2.5k 2.6× 491 0.9× 600 1.1× 80 7.5k
D Y Mason 701 0.2× 387 0.4× 1.6k 1.7× 468 0.8× 504 0.9× 72 5.5k
S L Kunkel 924 0.3× 673 0.7× 1.2k 1.3× 423 0.7× 261 0.5× 49 5.8k

Countries citing papers authored by David Waltz

Since Specialization
Citations

This map shows the geographic impact of David Waltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Waltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Waltz more than expected).

Fields of papers citing papers by David Waltz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Waltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Waltz. The network helps show where David Waltz may publish in the future.

Co-authorship network of co-authors of David Waltz

This figure shows the co-authorship network connecting the top 25 collaborators of David Waltz. A scholar is included among the top collaborators of David Waltz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Waltz. David Waltz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Joon Lee Breakdown of academic impact, for papers by Simon Halegoua Breakdown of academic impact, for papers by Chiaki Kobayashi Breakdown of academic impact, for papers by C. Randall Colvin Breakdown of academic impact, for papers by Joseph L. Mahoney Breakdown of academic impact, for papers by Hao Ding Breakdown of academic impact, for papers by Julie Audet Breakdown of academic impact, for papers by Friedrich K. Stephan
Rankless by CCL
2026